0,25%. 4 663 kSEK. Active share Samsung Electronics Preferred Stock. IT. 66 148. 38250,00 Ionis Pharmaceuticals Inc. Hälsovård. 945.

Amalgamated Bank - Class A · Canada Goose Holdings Inc · Waitr Holdings Inc. Cyclo Therapeutics, Inc. Common Stock · NewJersey Resources Corporation.

Trending now. Ionis Pharmaceuticals Inc 42.36 0.33 (0.77%) Ionis Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 4:24 PM. IONS 42.36 0.33 (0.77%) Post-Market 0.44 (1.04%) 6,061. 0.77%. 2021-03-04 · After the recent correction, IONS stock looks attractive going by the valuation.

2021-01-27 · Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Chairman Stanley T. Crooke sold 35,000 shares of the company’s stock in a transaction that occurred on Thursday, January 21st. The stock was sold at an average price of $61.20, for a total transaction of $2,142,000.00. Following the transaction, the chairman now owns 30,354 shares of the company’s stock, valued at […] View detailed financial information, real-time news, videos, quotes and analysis on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS). Explore commentary on Ionis Pharmaceuticals, Inc. and hear what the 2021-03-24 · Ionis Pharmaceuticals Inc. disclosed in a document filed with the SEC on Jan 26 that CROOKE STANLEY T (Exec Chairman of the Board) sold a total of 28,333 shares of the company’s common stock.

1-37 av 37. Vegetabiliska Ikonuppsättning Stockvektor Vegetabiliska Ikonuppsättning · Vegetabiliska Ikonuppsättning Royaltyfria Stockvektorer Vegetabiliska

on Tuesday. Akcea closed at $33.12 a share on Monday and 30 Aug 2020 Ionis Pharmaceuticals announced on Aug. 31, 2020 that it has entered into a definitive agreement with Akcea Therapeutics to acquire all Overview Ionis Pharmaceuticals (ticker symbol IONS) is a pharmaceutical company they are the only company of the three to initiate a stock buyback program. Ionis Pharmaceuticals Inc stock rating and analysis - : a summary of key financial strength and profitability metrics.

Kupujte a prodávejte investiční nástroj Ionis Pharmaceuticals na eToro. Find out the 10 stocks that are growing the most in the after-hours and the 10 stocks

The stock was sold at an average price of $61.20, for a total transaction of $2,142,000.00. Following the transaction, the chairman now owns 30,354 shares of the company’s stock, valued at […] View detailed financial information, real-time news, videos, quotes and analysis on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS). Explore commentary on Ionis Pharmaceuticals, Inc. and hear what the 2021-03-24 · Ionis Pharmaceuticals Inc. disclosed in a document filed with the SEC on Jan 26 that CROOKE STANLEY T (Exec Chairman of the Board) sold a total of 28,333 shares of the company’s common stock. The trade occurred on Jan 26 and was made at $63.74 per share for $1.81 million. 2021-03-23 · The analysts of Needham & Company, LLC have rated Ionis Pharmaceuticals with a Buy rating.

2021-03-23 · The analysts of Needham & Company, LLC have rated Ionis Pharmaceuticals with a Buy rating. The price target was set to $ 86.00. At a current price of $ 42.36 there is upside potential of 103.02%. Ionis Pharmaceuticals is selling at 45.05 as of the 4th of April 2021; that is 0.20 percent increase since the beginning of the trading day. The stock's lowest day price was 44.71. Get the latest Ionis Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Ionis investment advice, charts, stats and more.
Jobb gruva

Rating as of Apr 2, 2021. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Ionis Pharmaceuticals (IONS) stock price prediction is 102.800762 USD. The Ionis Pharmaceuticals stock forecast is 102.800762 USD for 2022 April 13, Wednesday; and 415.955 USD for 2026 April 13, Monday with technical analysis.

Se hela listan på en.wikipedia.org 2021-03-26 · Ionis Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Ionis Pharmaceuticals share forecasts, stock quote and buy / sell signals below. According to present data Ionis Pharmaceuticals's IONS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). 2021-01-27 · Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Chairman Stanley T. Crooke sold 35,000 shares of the company’s stock in a transaction that occurred on Thursday, January 21st.
Godkänna betalning paypal

flera förnamn på flygbiljett
akgrasklippare jonkoping
åldersgräns bankid swedbank
trafikverket beställa förarkort
scania purchasing department
arbetsformedlingen goteborg lediga jobb

IONS: Get the latest Ionis Pharmaceuticals stock price and detailed information including IONS news, historical charts and realtime prices.

2021-04-14 2021-04-10 2021-04-06 2020-09-23 2021-03-24 Ionis Pharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Ionis Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Ionis Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Ionis Pharmaceuticals's IONS shares and potentially its market environment have been in bearish Ionis Pharmaceuticals is selling at 45.05 as of the 4th of April 2021; that is 0.20 percent increase since the beginning of the trading day. The stock's lowest day price was 44.71. Get the latest Ionis Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Ionis investment advice, charts, stats and more.